drugset / Trial / NCT00550095
To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to assess the efficacy of the different dosage forms of Valsartan\[80, 160, and 320 mg\] in reducing microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valsartan | Small molecule | 80 mg | — |
| Subject | Valsartan | Small molecule | 160 mg | — |
| Subject | Valsartan | Small molecule | 320 mg | — |